These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Wright JT; Probstfield JL; Cushman WC; Pressel SL; Cutler JA; Davis BR; Einhorn PT; Rahman M; Whelton PK; Ford CE; Haywood LJ; Margolis KL; Oparil S; Black HR; Alderman MH; Arch Intern Med; 2009 May; 169(9):832-42. PubMed ID: 19433694 [TBL] [Abstract][Full Text] [Related]
6. All hats off to ALLHAT: a massive study with clear messages. Chalmers J J Hypertens; 2003 Feb; 21(2):225-8. PubMed ID: 12569241 [No Abstract] [Full Text] [Related]
7. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial]. Düsing R Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115 [No Abstract] [Full Text] [Related]
8. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study]. Schillaci G; Verdecchia P Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297 [No Abstract] [Full Text] [Related]
9. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension]. Higashiura K Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446 [No Abstract] [Full Text] [Related]
10. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2? Nicholls MG J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907 [No Abstract] [Full Text] [Related]
11. Safety and efficacy of first-line antihypertensives. Strickland C J Fam Pract; 1997 Jun; 44(6):530-1. PubMed ID: 9191619 [No Abstract] [Full Text] [Related]
12. Contrasting messages but not contradicting results from ALLHAT and ANBP2. Hedner T; Himmelmann A; Kjeldsen SE Blood Press; 2003; 12(2):68-9. PubMed ID: 12797626 [No Abstract] [Full Text] [Related]
13. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient. Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474 [No Abstract] [Full Text] [Related]
14. The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension. Appel LJ JAMA; 2002 Dec; 288(23):3039-42. PubMed ID: 12479770 [No Abstract] [Full Text] [Related]
15. ALLHAT: still providing correct answers after 7 years. Einhorn PT; Davis BR; Wright JT; Rahman M; Whelton PK; Pressel SL; Curr Opin Cardiol; 2010 Jul; 25(4):355-65. PubMed ID: 20520537 [TBL] [Abstract][Full Text] [Related]
16. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors. Rollins G Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699 [No Abstract] [Full Text] [Related]
17. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue. Cardinal H; Monfared AA; Dorais M; LeLorier J Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318 [TBL] [Abstract][Full Text] [Related]
18. ALLHAT says diuretics are better; ANBP2 says ACEs are better--can we resolve the differences? Vidt DG Cleve Clin J Med; 2004 Feb; 71(2):145-50. PubMed ID: 14982197 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive treatment and CHD in the elderly. Fink KS; Ellsworth A Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742 [No Abstract] [Full Text] [Related]